+971 4 255 2616
+971 4 255 2922

Corindus Vascular Robotics

  • Description


Corindus Vascular Robotics, Inc. is a global technology leader in robotic-assisted vascular interventions. The company’s CorPath® System is the first FDA-cleared medical device to bring robotic-assisted precision to radial, coronary and peripheral procedures. During the procedure, the interventional cardiologist sits at a radiation-shielded workstation to advance stents and guidewires with millimeter-by-millimeter precision.

The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries. With the CorPath System, Corindus Vascular Robotics brings robotic precision to radial and complex interventional procedures to help optimize clinical outcomes and minimize the costs associated with complications of improper stent placement with manual procedures.

What is Robotic-assisted PCI?

Today, many procedures that were once highly invasive are now being performed via minimally invasive techniques and with the added benefit of robotic precision. Since the introduction of percutaneous coronary intervention (PCI) almost 40 years ago, there has been an astonishing amount of advancement in the technology and devices used in the procedure, but how the procedure is performed has remained virtually unchanged. Physicians are still standing at the patient’s bedside next to the X-ray source, manually manipulating their devices during intervention.

The CorPath System is the first FDA cleared robotic system designed to aid interventional cardiologists in performing PCI. During robotic-assisted PCI, physicians sit in a radiation-shielded workstation, the Interventional Cockpit, and use a set of joysticks and touchscreen controls to robotically manipulate guidewires and balloon/stent catheters during an intervention. These controls translate the physicians movements into movements of devices such as advancing and torqueing guidewires and advancing balloons or stents in movements as small as a millimeter. In clinical trials, CorPath has been shown to reduce radiation exposure for the primary operator by over 95%1 and has the potential to enable reduced radiation exposure for the entire cath lab team. In addition, the system has the ability to measure anatomy with sub-millimeter precision and to position stents with 1 millimeter movements, which can potentially improve patient outcomes.